STAGE II LIP AND ORAL CAVITY CANCER AJCC V8
Clinical trials for STAGE II LIP AND ORAL CAVITY CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II LIP AND ORAL CAVITY CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II LIP AND ORAL CAVITY CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to improve survival in recurrent head and neck cancer
Disease control Recruiting nowThis study tests whether adding chemotherapy or a chemo-immunotherapy combination before salvage surgery can improve outcomes for people with head and neck cancer that has returned or persisted. About 180 participants with PD-L1 positive tumors will receive either standard surger…
Matched conditions: STAGE II LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
Could a smaller surgery spare oral cancer patients from shoulder problems?
Disease control Recruiting nowThis study tests whether a less invasive procedure called sentinel lymph node biopsy works as well as the standard neck dissection for people with early-stage oral cavity cancer. The sentinel biopsy removes only a few key lymph nodes, while standard surgery removes many. The goal…
Matched conditions: STAGE II LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
New drug aims to prevent painful mouth sores in head and neck cancer treatment
Symptom relief Recruiting nowThis study tests whether adding BMX-001 to standard care can reduce severe mouth sores caused by chemoradiation in head and neck cancer patients. About 98 participants will receive either BMX-001 or a placebo alongside usual mouth rinses and pain medications. The goal is to impro…
Matched conditions: STAGE II LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC